Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study.

[1]  C. Meisinger,et al.  Leptin, adiponectin, their ratio and risk of Coronary Heart Disease: results from the MONICA/KORA Augsburg Study 1984-2002. , 2010, Atherosclerosis.

[2]  C. Mantzoros,et al.  Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications , 2010, Annals of Internal Medicine.

[3]  L. Rui,et al.  Recent advances in understanding leptin signaling and leptin resistance. , 2009, American journal of physiology. Endocrinology and metabolism.

[4]  C. Lavie,et al.  Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. , 2009, Journal of the American College of Cardiology.

[5]  J. Danesh,et al.  Leptin and coronary heart disease: prospective study and systematic review. , 2009, Journal of the American College of Cardiology.

[6]  E. Vittinghoff,et al.  Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. , 2008, JAMA.

[7]  L. Barouch,et al.  Leptin signaling and obesity: cardiovascular consequences. , 2007, Circulation research.

[8]  D. Lawlor,et al.  Leptin and Coronary Heart Disease Risk: Prospective Case Control Study of British Women , 2007, Obesity.

[9]  W. Zidek,et al.  Low Serum Leptin Predicts Mortality in Patients with Chronic Kidney Disease Stage 5 , 2007, Obesity.

[10]  F. Hu,et al.  Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study , 2007, Diabetologia.

[11]  W. Rathmann,et al.  Adiponectin and Cardiovascular Mortality: Evidence for “Reverse Epidemiology” , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[12]  D. Yellon,et al.  Leptin, the obesity‐associated hormone, exhibits direct cardioprotective effects , 2006, British journal of pharmacology.

[13]  V. Somers,et al.  Leptin receptor and functional effects of leptin in human endothelial progenitor cells. , 2005, Atherosclerosis.

[14]  Bruce D. Johnson,et al.  Plasma leptin and prognosis in patients with established coronary atherosclerosis. , 2004, Journal of the American College of Cardiology.

[15]  T. Hedner,et al.  Serum leptin and myocardial infarction in hypertension , 2004, Blood pressure.

[16]  L. Luzi,et al.  Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. , 2003, Diabetes care.

[17]  J. Rumsfeld,et al.  Depressive symptoms and health-related quality of life: the Heart and Soul Study. , 2003, JAMA.

[18]  R. Westrick,et al.  Effect of leptin on arterial thrombosis following vascular injury in mice. , 2002, JAMA.

[19]  L. Fratta,et al.  Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. , 2002, Diabetes.

[20]  N. Sattar,et al.  Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.

[21]  L. Fratta,et al.  Leptin induces direct vasodilation through distinct endothelial mechanisms. , 2000, Diabetes.

[22]  T. Olsson,et al.  Leptin is associated with increased risk of myocardial infarction , 1999, Journal of internal medicine.

[23]  R. Busse,et al.  Leptin induces oxidative stress in human endothelial cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  G. Dagenais,et al.  Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study , 1998, Diabetes Care.

[25]  W. Alvord,et al.  Interleukin 1α Increases Serum Leptin Concentrations in Humans , 1997 .

[26]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.